scholarly article | Q13442814 |
P50 | author | Debra I Diz | Q65602887 |
P2093 | author name string | Mark C Chappell | |
Carlos M Ferrario | |||
Patricia E Gallagher | |||
E Ann Tallant | |||
Ellen N Tommasi | |||
Maria A Garcia-Espinosa | |||
Stephen Gegick | |||
P2860 | cites work | Evidence that angiotensin-(1–7) plays a role in the central control of blood pressure at the ventro-lateral medulla acting through specific receptors | Q62124902 |
Rapid resetting of the baroreceptors in renal hypertensive rats | Q68699231 | ||
Time course of baroreceptor resetting in acute hypertension | Q71413240 | ||
Opposite effects of angiotensin AT1 and AT2 receptor antagonists on recovery of mechanical function after ischemia-reperfusion in isolated working rat hearts | Q71958318 | ||
Does angiotensin II have a significant tonic action on cardiovascular neurons in the rostral and caudal VLM? | Q72998020 | ||
Pathways for angiotensin-(1---7) metabolism in pulmonary and renal tissues | Q73127508 | ||
Neurochemical transmission of baroreceptor input in the nucleus tractus solitarius | Q73531342 | ||
Metabolism of angiotensin-(1-7) by angiotensin-converting enzyme | Q74132686 | ||
The cardiovascular effects of angiotensin-(1-7) in the rostral and caudal ventrolateral medulla of the rabbit | Q74297009 | ||
Primary role of angiotensin-converting enzyme-2 in cardiac production of angiotensin-(1-7) in transgenic Ren-2 hypertensive rats | Q79793849 | ||
Angiotensin metabolism in renal proximal tubules, urine, and serum of sheep: evidence for ACE2-dependent processing of angiotensin II | Q80077979 | ||
Central and peripheral cardiovascular actions of apelin in conscious rats | Q81103358 | ||
Cardiovascular effects of angiotensin-(1-7) injected into the dorsal medulla of rats | Q93533876 | ||
Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism | Q24300310 | ||
ACE2: a new target for cardiovascular disease therapeutics | Q24337633 | ||
Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase | Q28115041 | ||
Emerging roles of apelin in biology and medicine | Q28252002 | ||
Physiological role of a novel neuropeptide, apelin, and its receptor in the rat brain. | Q30032204 | ||
Angiotensin peptides and baroreflex control of sympathetic outflow: pathways and mechanisms of the medulla oblongata | Q33858515 | ||
Angiotensin peptides as neurotransmitters/neuromodulators in the dorsomedial medulla | Q34636700 | ||
Differential expression of neuronal ACE2 in transgenic mice with overexpression of the brain renin-angiotensin system | Q35567432 | ||
Differential cardiovascular and respiratory responses to central administration of selective opioid agonists in conscious rabbits: correlation with receptor distribution | Q35756851 | ||
Angiotensin-converting enzyme-2: a molecular and cellular perspective | Q35953162 | ||
Modulation of reflex function by endogenous angiotensins in older transgenic rats with low glial angiotensinogen | Q36791617 | ||
Aging and the brain renin-angiotensin system: insights from studies in transgenic rats. | Q36800252 | ||
Emerging evidence for a functional angiotensin-converting enzyme 2-angiotensin-(1-7)-MAS receptor axis: more than regulation of blood pressure? | Q36929193 | ||
Functions of angiotensin peptides in the rostral ventrolateral medulla. | Q37818466 | ||
Histochemical visualization of neutral endopeptidase-24.11 (enkephalinase) activity in rat brain: cellular localization and codistribution with enkephalins in the globus pallidus | Q41282731 | ||
Functions of angiotensin peptides in the rostral ventrolateral medulla. | Q41309129 | ||
Differential baroreceptor reflex modulation by centrally infused angiotensin peptides | Q42462109 | ||
Baroreflex depression persists in the early phase after hypertension reversal | Q43608292 | ||
Site-specific effects of apelin-13 in the rat medulla oblongata on arterial pressure and respiration | Q44236290 | ||
AT1 receptors in the RVLM mediate pressor responses to emotional stress in rabbits. | Q44374335 | ||
Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2. | Q46493539 | ||
Impaired heart rate baroreflex in older rats: role of endogenous angiotensin-(1-7) at the nucleus tractus solitarii | Q46595087 | ||
Distinct roles for ANG II and ANG-(1-7) in the regulation of angiotensin-converting enzyme 2 in rat astrocytes | Q46715078 | ||
Baroreceptor reflex modulation by angiotensin II at the nucleus tractus solitarii | Q48116025 | ||
Overexpression of angiotensin-converting enzyme 2 in the rostral ventrolateral medulla causes long-term decrease in blood pressure in the spontaneously hypertensive rats | Q48260358 | ||
Baroreceptor reflex regulation in anesthetized transgenic rats with low glia-derived angiotensinogen | Q48378454 | ||
In vivo metabolism of angiotensin I by neutral endopeptidase (EC 3.4.24.11) in spontaneously hypertensive rats | Q48478548 | ||
NK1 receptor antagonist blocks angiotensin II responses in renin transgenic rat medulla oblongata | Q48547429 | ||
Hypotensive actions of microinjections of angiotensin II into the dorsal motor nucleus of the vagus. | Q48591511 | ||
Acute depressor actions of angiotensin II in the nucleus of the solitary tract are mediated by substance P. | Q48667161 | ||
Immunocytochemical localization of endopeptidase-24.11 in the nucleus tractus solitarius of the rat brain | Q48898452 | ||
Responses to central Na(+) and ouabain are attenuated in transgenic rats deficient in brain angiotensinogen | Q48965458 | ||
Distribution of Angiotensin-Converting Enzyme Activity in Specific Areas of the Rat Brain Stem | Q49108656 | ||
Actions of angiotensin peptides after partial denervation of the solitary tract nucleus | Q49116844 | ||
Modulation of the baroreflex control of heart rate by angiotensin-(1-7) at the nucleus tractus solitarii of normotensive and spontaneously hypertensive rats | Q49127895 | ||
Changes in the Baroreflex Control of Heart Rate Produced by Central Infusion of Selective Angiotensin Antagonists in Hypertensive Rats | Q62124898 | ||
P433 | issue | 5 | |
P304 | page(s) | 694-700 | |
P577 | publication date | 2008-03-20 | |
P1433 | published in | Experimental Physiology | Q1091760 |
P1476 | title | Injections of angiotensin-converting enzyme 2 inhibitor MLN4760 into nucleus tractus solitarii reduce baroreceptor reflex sensitivity for heart rate control in rats | |
P478 | volume | 93 |
Q40159156 | ACE2-Ang-(1-7)-Mas Axis in Brain: A Potential Target for Prevention and Treatment of Ischemic Stroke |
Q34784864 | ACE2/ANG-(1-7)/Mas pathway in the brain: the axis of good. |
Q40097869 | Aging and the brain renin-angiotensin system: relevance to age-related decline in cardiac function |
Q37347019 | Angiotensin (1-7) contributes to nitric oxide tonic inhibition of vasopressin release during hemorrhagic shock in acute ethanol intoxicated rodents |
Q37225431 | Angiotensin II type 1 receptor-mediated reduction of angiotensin-converting enzyme 2 activity in the brain impairs baroreflex function in hypertensive mice |
Q35059998 | Angiotensin peptides and central autonomic regulation |
Q27022788 | Angiotensin peptides and nitric oxide in cardiovascular disease |
Q34150500 | Angiotensin-(1-12) requires angiotensin converting enzyme and AT1 receptors for cardiovascular actions within the solitary tract nucleus |
Q42554373 | Angiotensin-Converting Enzyme 2 (ACE2) Is a Key Modulator of the Renin Angiotensin System in Health and Disease |
Q37155907 | Angiotensin-converting enzyme 2 in the brain: properties and future directions |
Q37079211 | Angiotensin-converting enzyme 2 overexpression improves central nitric oxide-mediated sympathetic outflow in chronic heart failure |
Q34978620 | Angiotensin-converting enzyme 2: central regulator for cardiovascular function |
Q35550937 | Angiotensin-converting enzyme 2: the first decade |
Q34163441 | Angiotensin-converting enzyme inhibition, but not AT(1) receptor blockade, in the solitary tract nucleus improves baroreflex sensitivity in anesthetized transgenic hypertensive (mRen2)27 rats |
Q34423315 | Angiotensin-converting enzymes and drug discovery in cardiovascular diseases. |
Q35543326 | Augmented central nitric oxide production inhibits vasopressin release during hemorrhage in acute alcohol-intoxicated rodents |
Q42598998 | Baroreflex and somato-reflex control of blood pressure, heart rate and renal sympathetic nerve activity in the obese Zucker rat. |
Q38053075 | Brain renin-angiotensin system in the nexus of hypertension and aging |
Q33639490 | Brain-selective overexpression of human Angiotensin-converting enzyme type 2 attenuates neurogenic hypertension |
Q99240645 | COVID-19 associated atrial fibrillation: Incidence, putative mechanisms and potential clinical implications |
Q37342323 | Central losartan attenuates increases in arterial pressure and expression of FosB/ΔFosB along the autonomic axis associated with chronic intermittent hypoxia. |
Q27691407 | Central neural control of sympathetic nerve activity in heart failure following exercise training |
Q42031141 | Chronic activation of endogenous angiotensin-converting enzyme 2 protects diabetic rats from cardiovascular autonomic dysfunction |
Q55153307 | Dysregulation of the Renin-Angiotensin System and the Vasopressinergic System Interactions in Cardiovascular Disorders. |
Q36178549 | Exercise training normalizes enhanced sympathetic activation from the paraventricular nucleus in chronic heart failure: role of angiotensin II |
Q37054516 | Exercise training normalizes the blunted central component of the baroreflex in rats with heart failure: role of the PVN |
Q36033367 | Gene transfer of angiotensin-converting enzyme 2 in the nucleus tractus solitarius improves baroreceptor heart rate reflex in spontaneously hypertensive rats |
Q90989956 | Importance of AT1 and AT2 receptors in the nucleus of the solitary tract in cardiovascular responses induced by a high-fat diet |
Q42210462 | Increased expression of angiotensin II type 2 receptors in the solitary-vagal complex blunts renovascular hypertension. |
Q28742760 | Long-term systemic angiotensin II type 1 receptor blockade regulates mRNA expression of dorsomedial medulla renin-angiotensin system components |
Q36977764 | MAP kinase/phosphatase pathway mediates the regulation of ACE2 by angiotensin peptides |
Q38093218 | Neuromodulatory role of angiotensin-(1-7) in the central nervous system |
Q37712468 | Neuronal over-expression of ACE2 protects brain from ischemia-induced damage |
Q37264506 | Portal pressure responses and angiotensin peptide production in rat liver are determined by relative activity of ACE and ACE2. |
Q38211744 | Protective axis of the renin-angiotensin system in the brain |
Q98176768 | Psychiatric face of COVID-19 |
Q37768187 | Renin-angiotensin system blockers and modulation of radiation-induced brain injury |
Q49135151 | Role of angiotensin-(1-7) in rostral ventrolateral medulla in blood pressure regulation via sympathetic nerve activity in Wistar-Kyoto and spontaneous hypertensive rats |
Q99724031 | Syncope at SARS-CoV-2 onset |
Q47851502 | The ACE2/Angiotensin-(1-7)/MAS Axis of the Renin-Angiotensin System: Focus on Angiotensin-(1-7). |
Q33677369 | Therapeutic implications of the vasoprotective axis of the renin-angiotensin system in cardiovascular diseases |
Q37769761 | Trilogy of ACE2: a peptidase in the renin-angiotensin system, a SARS receptor, and a partner for amino acid transporters |
Q37454928 | Update on the Angiotensin converting enzyme 2-Angiotensin (1-7)-MAS receptor axis: fetal programing, sex differences, and intracellular pathways |
Search more.